Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 3, Issue 5

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 3, Issue 5 (1994)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 3, Issue 5 (1994)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Volume 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Research

Article

Editorial Commentary

J Desmond Fitzgerald

Pages: 425-426

Published online: 03 Mar 2008

CitationforEditorial Commentary | References | PDF (196 KB)

3 Views
0 CrossRef citations
0Altmetric

Article

Section Review: Cardiovascular and Renal: ACAT inhibitors in development

Hiroshi Tanaka & Teiji Kimura

Pages: 427-436

Published online: 03 Mar 2008

AbstractforSection Review: Cardiovascular and Renal: ACAT inhibitors in development | References | PDF (934.8 KB)

17 Views
10 CrossRef citations
0Altmetric

Article

Fibrinogen receptor antagonists

Jeffery A. Zablocki, Nancy S. Nicholson & Larry P. Feigen

Pages: 437-448

Published online: 03 Mar 2008

AbstractforFibrinogen receptor antagonists | References | PDF (1.2 MB)

49 Views
11 CrossRef citations
0Altmetric

Article

Clopidogrel and antiplatelet therapy

Jean-Marc Herbert

Pages: 449-455

Published online: 03 Mar 2008

AbstractforClopidogrel and antiplatelet therapy | References | PDF (764.3 KB)

92 Views
14 CrossRef citations
0Altmetric

Article

Inotropic agents in development

P Dorigo, G Santostasi, D Fraccarollo & I Maragno

Pages: 457-468

Published online: 03 Mar 2008

AbstractforInotropic agents in development | References | PDF (1.2 MB)

15 Views
7 CrossRef citations
0Altmetric

Article

Recent progress in the clinical development of thromboxane A₂ receptor antagonists

Raj N Misra

Pages: 469-480

Published online: 03 Mar 2008

AbstractforRecent progress in the clinical development of thromboxane A₂ receptor antagonists | References | PDF (1.2 MB)

18 Views
10 CrossRef citations
0Altmetric

Article

Novel agents in the treatment of atherosclerosis

Robin Fears, Keith Suckling & George Poste

Pages: 481-491

Published online: 03 Mar 2008

AbstractforNovel agents in the treatment of atherosclerosis | References | PDF (1.1 MB)

5 Views
1 CrossRef citations
0Altmetric

Article

Bile acid sequestrants

G Martin Benson & Deirdre MB Hickey

Pages: 493-500

Published online: 03 Mar 2008

AbstractforBile acid sequestrants | References | PDF (683 KB)

29 Views
5 CrossRef citations
0Altmetric

Article

Potential effects of bradykinin on myocardial capillary growth after angiotensin converting enzyme inhibition

Carsten Tschöpe, Monika Stoll, Peter Gohlke & Thomas Unger

Pages: 501-510

Published online: 03 Mar 2008

AbstractforPotential effects of bradykinin on myocardial capillary growth after angiotensin converting enzyme inhibition | References | PDF (1.1 MB)

6 Views
3 CrossRef citations
0Altmetric

Article

Modern 5-HT receptor classification and 5-HT based drugs

Pramod R Saxena

Pages: 513-523

Published online: 03 Mar 2008

AbstractforModern 5-HT receptor classification and 5-HT based drugs | References | PDF (975.9 KB)

19 Views
13 CrossRef citations
0Altmetric

Article

Selective and non-selective cyclic nucleotide phosphodiesterase inhibitors and heart failure - is there a way ahead?

C D Nicholson

Pages: 525-528

Published online: 03 Mar 2008

First Page PreviewforSelective and non-selective cyclic nucleotide phosphodiesterase inhibitors and heart failure - is there a way ahead? | References | PDF (423.2 KB)

4 Views
0 CrossRef citations
0Altmetric

Article

Inhibition of nitric oxide synthesis as a therapeutic target for arthritis: recent reports

Felicia R Cochran

Pages: 529-531

Published online: 03 Mar 2008

First Page PreviewforInhibition of nitric oxide synthesis as a therapeutic target for arthritis: recent reports | References | PDF (315.4 KB)

5 Views
1 CrossRef citations
0Altmetric

Article

A biotechnology perspective: are peptides a vogue or a transition?

Patrick J Scannon

Pages: 533-534

Published online: 03 Mar 2008

CitationforA biotechnology perspective: are peptides a vogue or a transition? | References | PDF (228.7 KB)

4 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.3, Iss.5, 1994)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?